ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Letter to HCFA Outlines Positions, Offers Glimpse of Tactics

September 27, 1996

Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities

December 8, 1989

Medenica’s Privileges Extended; Patient sue Hilton Head Physicians

June 4, 1993

Small Business Technology Transfer Program Solicitation

June 23, 1995

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010